Using hydroxychloroquine to improve pregnancy outcomes in women with Type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of hydroxychloroquine as an additional treatment for pregnant women diagnosed with Type 2 diabetes. Participants will be randomly assigned to either a control group receiving standard treatment or an intervention group receiving hydroxychloroquine alongside standard care. The study will measure various outcomes, including pregnancy results and inflammatory markers, through blood tests and regular monitoring of blood glucose levels. Follow-up will include fetal growth assessments via ultrasound and regular consultations with a specialized care team.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Singleton
* Pregnant women with a confirmed diagnosis of type 2 Diabetes Mellitus

Exclusion Criteria:

* autoimmune disease such as Systemic Lupus Erythematosus or rheumatic disease
* chronic kidney disease
* fetal anomaly
* women on steroid therapy
* diabetic retinopathy
* known thalassaemia or thalassaemia carrier

Where it's running

• Antenatal clinic, UKM Medical Centre
  Cheras, Kuala Lumpur, Malaysia Recruiting

Study contacts

• Principal investigator: Rahana Abd Rahman — Ukm
• Study coordinator: Rahana Abdul Rahman, MD
• Email: drrahana@ukm.edu.my
• Phone: 039145

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.